Abiopharma

enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants

enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants

Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Securities Fraud Investigation Into Perrigo Company plc (PRGO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

What Flexibility Built: How Remote Work Opened Doors for Women in STEM — and What’s at Stake as They Close

A passion for patients and plasma donors drives Takeda’s BioLife employees

Kodiak Sciences to Present at Upcoming Investor Conferences